Literature DB >> 15118390

Nephrogenic fibrosing dermopathy treated with extracorporeal photopheresis.

Severin Läuchli1, Claudia Zortea-Caflisch, Frank O Nestle, Günter Burg, Werner Kempf.   

Abstract

Nephrogenic fibrosing dermopathy (NFD) is a rare fibrosing skin disease of unknown etiology occurring in patients with terminal renal disease. It was first described in the year 2000. The histology of NFD shows an increased number of dendritic cells, fibroblasts and thickened collagen fibers resembling scleromyxedema. It can be distinguished from scleromyxedema by a different distribution pattern of the skin lesions with indurated plaques mainly on the extremities and the absence of paraproteinemia. As yet, no treatment for NFD has been proven to be uniformly efficient. We describe the case of a 40-year old patient with renal insufficiency who was treated with hemodialysis and who had undergone kidney transplantation. Two years after transplantation, she developed sclerodermiform brownish plaques on her extremities. The induration improved significantly after 4 cycles of extracorporeal photopheresis. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2004        PMID: 15118390     DOI: 10.1159/000077321

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  12 in total

1.  Guidelines on the use of extracorporeal photopheresis.

Authors:  R Knobler; G Berlin; P Calzavara-Pinton; H Greinix; P Jaksch; L Laroche; J Ludvigsson; P Quaglino; W Reinisch; J Scarisbrick; T Schwarz; P Wolf; P Arenberger; C Assaf; M Bagot; M Barr; A Bohbot; L Bruckner-Tuderman; B Dreno; A Enk; L French; R Gniadecki; H Gollnick; M Hertl; C Jantschitsch; A Jung; U Just; C-D Klemke; U Lippert; T Luger; E Papadavid; H Pehamberger; A Ranki; R Stadler; W Sterry; I H Wolf; M Worm; J Zic; C C Zouboulis; U Hillen
Journal:  J Eur Acad Dermatol Venereol       Date:  2014-01       Impact factor: 6.166

2.  Nephrogenic fibrosing dermopathy in children.

Authors:  Ari Auron; Lei Shao; Bradley A Warady
Journal:  Pediatr Nephrol       Date:  2006-07-05       Impact factor: 3.714

Review 3.  Extracorporeal photopheresis as a therapy for autoimmune diseases.

Authors:  Zoya Kuzmina; David Stroncek; Steven Z Pavletic
Journal:  J Clin Apher       Date:  2014-12-26       Impact factor: 2.821

4.  [Nephrogenic systemic fibrosis].

Authors:  W Samtleben
Journal:  Radiologe       Date:  2007-09       Impact factor: 0.635

Review 5.  Nephrogenic systemic fibrosis: an emerging entity.

Authors:  Sandip K Saxena; Manjuri Sharma; Mital Patel; Dimitrios Oreopoulos
Journal:  Int Urol Nephrol       Date:  2008-04-17       Impact factor: 2.370

Review 6.  Nephrogenic systemic fibrosis and the use of gadolinium-based contrast agents.

Authors:  Jeffrey G Penfield
Journal:  Pediatr Nephrol       Date:  2008-06-10       Impact factor: 3.714

Review 7.  Description of 12 cases of nephrogenic fibrosing dermopathy and review of the literature.

Authors:  Fabian A Mendoza; Carol M Artlett; Nora Sandorfi; Kevin Latinis; Sonsoles Piera-Velazquez; Sergio A Jimenez
Journal:  Semin Arthritis Rheum       Date:  2006-02       Impact factor: 5.532

8.  Complications of nephrogenic systemic fibrosis following repeated exposure to gadolinium in a man with hypothyroidism: a case report.

Authors:  Arpita Aggarwal; Allison A Froehlich; Paulina Essah; Nooshin Brinster; Whitney A High; Robert W Downs
Journal:  J Med Case Rep       Date:  2011-12-07

9.  A unique case of nephrogenic systemic fibrosis from gadolinium exposure in a patient with normal eGFR.

Authors:  Sadichhya Lohani; Jon Golenbiewski; Abhishek Swami; Alexandra Halalau
Journal:  BMJ Case Rep       Date:  2017-10-11

Review 10.  Gadolinium and nephrogenic systemic fibrosis: time to tighten practice.

Authors:  Iosif A Mendichovszky; Stephen D Marks; Clare M Simcock; Oystein E Olsen
Journal:  Pediatr Radiol       Date:  2007-10-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.